To view the PDF file, sign up for a MySharenet subscription.

SASOL LIMITED - Dealings in securities by prescribed officers of Sasol and directors of major subsidiaries of Sasol

Release Date: 30/11/2020 17:32
Code(s): SOLBE1 SOL     PDF:  
Wrap Text
Dealings in securities by prescribed officers of Sasol and directors of major subsidiaries of Sasol

Sasol Limited
(Incorporated in the Republic of South Africa)
(Registration number 1979/003231/06)
Sasol Ordinary Share codes:          JSE: SOL                    NYSE: SSL
Sasol Ordinary ISIN codes:           ZAE000006896                US8038663006
Sasol BEE Ordinary Share code:       JSE: SOLBE1
Sasol BEE Ordinary ISIN code:        ZAE000151817
(“Sasol” or “Company”)

DEALINGS IN SECURITIES BY PRESCRIBED OFFICERS OF SASOL AND DIRECTORS OF
MAJOR SUBSIDIARIES OF SASOL

In compliance with paragraph 3.63 to 3.66 of the JSE Limited Listings Requirements (“Listings
Requirements”), Sasol hereby announces that prescribed officers of Sasol, and directors of major
subsidiaries of Sasol have, in terms of the Sasol Long-Term Incentive (“LTI”) Plan (“Plan”), been
issued shares in terms of previously accepted LTI awards as follows:

-      2015 award (balance vested) at the achievement of corporate performance targets of 47%
       (GEC) and 68,2% (SVP and lower) respectively, which were achieved over the performance
       period 2015 - 2018. The balance of 50% of these vested shares were subject to a 2-year
       retention period from 2018 - 2020.
-      2017 (50% of the vested award): at the achievement of corporate performance targets of 26%
       (GEC) and 56% (SVP and lower) respectively, which were achieved over the performance
       period 2017 - 2020. The balance of these shares (after application of the performance targets),
       will vest in 2022 subject to the rules of the Plan.

Participants have the option to retain all shares, sell sufficient shares to cover the tax liability and
retain the balance of shares or to sell the vested shares. The dealings are as set out below.

    Vesting date:                         6 October 2020
    Class of shares:                      Sasol American Depositary Receipts (ADR) each representing one
                                          Sasol ordinary share
    Initial issue price per right:        USD0,00
    Nature of Transaction:                Retention of vested shares off-market
    Nature and extent of interest:        Direct beneficial

    Surname and      Designation          Company                    Number       Price per    Total value of
    initials                                                        of shares      share             the
                                                                                   (USD)        transaction
                                                                                                   (USD)
    Griffith, B V    Prescribed Officer   Sasol Limited                  3 056          7,42        22 675,52
                     Director             Sasol (USA) Corporation
    Harris, J R      Prescribed Officer   Sasol Limited                  1 466          7,42       10 877,72
    Thomas, M S      Director             Sasol (USA) Corporation        2 724          7,42       20 212,08
                                          Sasol Chemicals (USA)
                                          LLC

    Vesting date:                         6 October 2020
    Transaction date:                     27 November 2020
    Class of shares:                      Sasol American Depositary Receipts (ADR) each representing one
                                          Sasol ordinary share
    Initial issue price per right:        USD0,00
    Nature of Transaction:                Sale of vested shares on-market to cover the tax liability on the
                                          vested shares
    Nature and extent of interest:        Direct beneficial

    Surname and      Designation          Company                     Number      Average      Total value of
 initials                                                                              of           Selling             the
                                                                                     shares        Price per        transaction
                                                                                                    share*             (USD)
                                                                                                    (USD)
 Harris, J R          Prescribed Officer         Sasol Limited                           1 410           8,59            12 111,90
 Thomas, M S          Director                   Sasol (USA) Corporation                 2 367           8,59            20 332,53
                                                 Sasol Chemicals (USA)
                                                 LLC
* Average selling price per share is based on transactions effected by the Company on 27 November 2020. Proceeds are allocated to the
shares sold by directors, as with all employees, based on the outcome of the bulk sale.


The highest and lowest prices, as well as VWAP price for the day of trading are as follows:

 Date                                                     Highest           Lowest price         Volume Weighted Average
                                                          price                                  Price
 27 November 2020                                         8,72              8,37                 8,59



In terms of paragraph 3.66 of the Listings Requirements, the necessary clearance to deal has been
obtained for all the transactions set out above.

30 November 2020
Sandton

Sponsor: Merrill Lynch South Africa Proprietary Limited

Date: 30-11-2020 05:32:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story